Cite
MLA Citation
V Dufner et al.. “P04.17 Antigen heterogeneity in glioblastoma cell lines, patient-derived cells, and patients' glioblastoma tissue is an obstacle for CAR-T cell therapy development.” Neuro-oncology, vol. 23, 2021, pp. ii21–ii22. http://access.bl.uk/ark:/81055/vdc_100140626142.0x000020